Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:706808.
doi: 10.1155/2015/706808. Epub 2015 May 11.

Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review

Alberto Zaniboni  1 , Giordano Savelli  2 , Claudio Pizzocaro  2 , Pietro Basile  2 , Valentina Massetti  2
Affiliations
Review

Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review

Alberto Zaniboni et al. Gastroenterol Res Pract. 2015.

Abstract

The aim of the present paper is to review the scientific literature concerning the usefulness of (18)F-FDG PET/CT in the evaluation of response to chemotherapy in patients affected by liver metastases from colorectal cancer. Material and Methods. Studies were identified by searching PubMed electronic databases. Both prospective and retrospective studies were included. Information regarding the figure of merit of PET for the evaluation of therapy response was extracted and analyzed. Results. Existing data suggests that (18)F-FDG PET/CT may have an outstanding role in evaluating the response. The sensitivity of PET in detecting therapy response seems to be greater than conventional imaging (CT and MRI). PET/CT response is strictly related to better overall survival and progression-free survival. Conclusions. PET/CT is more than a promising technique to assess the response to chemotherapy in colorectal and liver metastases. However, to be fully validated, this examination needs further studies by recruiting more patients.

PubMed Disclaimer

References

    1. Herbertson R. A., Scarsbrook A. F., Lee S. T., Tebbutt N., Scott A. M. Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clinical Radiology. 2009;64(3):225–237. doi: 10.1016/j.crad.2008.08.008. - DOI - PubMed
    1. Fletcher J. W., Djulbegovic B., Soares H. P., et al. Recommendations on the use of 18F-FDG PET in oncology. Journal of Nuclear Medicine. 2008;49(3):480–508. doi: 10.2967/jnumed.107.047787. - DOI - PubMed
    1. Figueiras R. G., Goh V., Padhani A. R., Naveira A. B., Caamaño A. G., Martin C. V. The role of functional imaging in colorectal cancer. American Journal of Roentgenology. 2010;195(1):54–66. doi: 10.2214/AJR.10.4422. - DOI - PubMed
    1. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization; 1979. (WHO Offset Publication no. 48).
    1. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207–214. - PubMed

LinkOut - more resources